Tradestie Institutional Equity Comparison Engine

NTLA vs PHVS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PHVS Overall Edge

PHVS Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pharvaris N.V. Ordinary Shares (PHVS) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NTLA trades at N/M Forward P/E with -826.0% operating margin (-48.0% YoY revenue) versus PHVS at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NTLA sits in BREAKDOWN (78th %ile IV; Dealer Gamma Walls on Pro) against PHVS sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
NTLA N/M vs PHVS N/M Fwd P/E
Growth & Margin Winner PHVS
Op Margin -826.0% vs 0.0% ยท YoY -48.0% vs +0.0%
Momentum & Technical Winner PHVS
1Y +15.3% vs +34.4% ยท 52W Pos 20% vs 48%
Options & Structure Winner PHVS
BREAKDOWN (78th %ile IV) vs CONSOLIDATION (7th %ile IV)
NTLA NASDAQ
Intellia Therapeutics, Inc
In Vitro & In Vivo Diagnostic Substances
$10.00
+3.09% 1D
Market Cap $1.5B
1M Return -12.43%
1Y Return +15.34%
Forward P/E N/M
Unified AI Score
49.9 / 100 HOLD
Tech 47.0 Fund 55.0 Flow 59.0 Mom 60.0
PHVS NASDAQ
Pharvaris N.V. Ordinary Shares
Pharmaceutical Preparations
$32.61
-2.25% 1D
Market Cap $2.4B
1M Return +17.56%
1Y Return +34.42%
Forward P/E N/M
Unified AI Score
44.1 / 100 HOLD
Tech 37.0 Fund 47.0 Flow 58.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NTLA +15.34% PHVS +34.42% Spread: +19.08 pp (PHVS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NTLA TTM Op. Margin: -826.0% PHVS TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NTLA vs PHVS. Trailing 12-month operating profitability (NTLA -826.0% vs PHVS 0.0%) and valuation multiples (NTLA N/M vs PHVS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NTLA (2) vs PHVS (5)
Institutional Metric NTLA PHVS Criterion Row Winner
Market Capitalization Scale $1.5B $2.4B Larger Scale PHVS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -48.0% +0.0% Higher Growth PHVS
Operating Margin (TTM) Profitability -826.0% 0.0% Higher Margin PHVS
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -62.6% -70.5% Higher ROE NTLA
52-Week Range Position Momentum 20% ($8โ€“$18) 48% ($23โ€“$43) Stronger Trend PHVS
Beta / 30D Volatility Risk Regime 2.30ฮฒ ยท 87% Vol 0.67ฮฒ ยท 38% Vol Lower Realized Risk PHVS
Unified Institutional Score Composite Signal 49.9 / 100 (HOLD) 44.1 / 100 (HOLD) Higher Composite NTLA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NTLA vs PHVS Buy Guide
NTLA BREAKDOWN
94d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 78th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live NTLA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PHVS CONSOLIDATION
105d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live PHVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NTLA nor PHVS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.